{
  "objCls" : "Guideline",
  "@id" : "https://www.pharmgkb.org/data/guideline/PA166114461",
  "@context" : "https://www.pharmgkb.org/jsonld/guideline.jsonld",
  "id" : "PA166114461",
  "name" : "CPIC Dosing Guideline for ivacaftor and CFTR",
  "guides" : [ {
    "locus" : "CFTR",
    "locusId" : "PA109",
    "alleles" : [ "F508del(CTT)", "F508del(TCT)", "G1244E", "G1349D", "G178R", "G551D", "G551S", "S1251N", "S1255P", "S549N", "S549R(A>C)", "S549R(T>G)", "other" ],
    "anns" : [ {
      "id" : 1183698546,
      "diplotypeIds1" : [ "PA166117965" ],
      "diplotypeIds2" : [ "PA166117965" ],
      "drug" : {
        "objCls" : "Drug",
        "@id" : "https://www.pharmgkb.org/data/drug/PA165950341",
        "@context" : "https://www.pharmgkb.org/jsonld/drug.jsonld",
        "id" : "PA165950341",
        "name" : "ivacaftor"
      },
      "groups" : [ {
        "@id" : "https://www.pharmgkb.org/data/ontologyTerm/guidelineTags/guidelineTags:981501927",
        "@context" : "https://www.pharmgkb.org/jsonld/ontologyTerm.jsonld",
        "id" : 981501927,
        "src" : "guidelineTags",
        "term" : "Phenotype (Genotype)",
        "termId" : "guidelineTags:981501927"
      } ],
      "location" : {
        "id" : 1184134919,
        "copyNumber" : "1",
        "diplotypes" : [ {
          "id" : 1184134920,
          "allele1" : "G551D",
          "allele2" : "G551D"
        } ],
        "displayName" : "CFTR G551D",
        "genes" : [ {
          "objCls" : "Gene",
          "@id" : "https://www.pharmgkb.org/data/gene/PA109",
          "@context" : "https://www.pharmgkb.org/jsonld/gene.jsonld",
          "id" : "PA109",
          "symbol" : "CFTR",
          "name" : "cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7)"
        } ],
        "gpPosition" : -1,
        "haplotypes" : [ {
          "objCls" : "Haplotype",
          "@id" : "https://www.pharmgkb.org/data/haplotype/PA166117965",
          "@context" : "https://www.pharmgkb.org/jsonld/haplotype.jsonld",
          "id" : "PA166117965",
          "name" : "G551D"
        } ],
        "refSeqPosition" : -1,
        "tagGene" : false,
        "type" : "haplotype"
      },
      "strength" : {
        "@id" : "https://www.pharmgkb.org/data/ontologyTerm/guidelineStrength/guidelineStrength:981501929",
        "@context" : "https://www.pharmgkb.org/jsonld/ontologyTerm.jsonld",
        "id" : 981501929,
        "src" : "guidelineStrength",
        "term" : "N/A",
        "termId" : "guidelineStrength:981501929"
      },
      "textHtml" : "<p>Cystic Fibrosis patient homozygous for G551D-CFTR (<a href=\"/rsid/rs75527207\">rs75527207</a> genotype AA). </p>"
    }, {
      "id" : 1183698555,
      "diplotypeIds1" : [ "PA166117965" ],
      "diplotypeIds2" : [ null ],
      "drug" : {
        "objCls" : "Drug",
        "@id" : "https://www.pharmgkb.org/data/drug/PA165950341",
        "@context" : "https://www.pharmgkb.org/jsonld/drug.jsonld",
        "id" : "PA165950341",
        "name" : "ivacaftor"
      },
      "groups" : [ {
        "@id" : "https://www.pharmgkb.org/data/ontologyTerm/guidelineTags/guidelineTags:981501927",
        "@context" : "https://www.pharmgkb.org/jsonld/ontologyTerm.jsonld",
        "id" : 981501927,
        "src" : "guidelineTags",
        "term" : "Phenotype (Genotype)",
        "termId" : "guidelineTags:981501927"
      } ],
      "location" : {
        "id" : 1184134925,
        "copyNumber" : "1",
        "diplotypes" : [ {
          "id" : 1184134926,
          "allele1" : "G551D"
        } ],
        "displayName" : "CFTR G551D",
        "genes" : [ {
          "objCls" : "Gene",
          "@id" : "https://www.pharmgkb.org/data/gene/PA109",
          "@context" : "https://www.pharmgkb.org/jsonld/gene.jsonld",
          "id" : "PA109",
          "symbol" : "CFTR",
          "name" : "cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7)"
        } ],
        "gpPosition" : -1,
        "haplotypes" : [ {
          "objCls" : "Haplotype",
          "@id" : "https://www.pharmgkb.org/data/haplotype/PA166117965",
          "@context" : "https://www.pharmgkb.org/jsonld/haplotype.jsonld",
          "id" : "PA166117965",
          "name" : "G551D"
        } ],
        "refSeqPosition" : -1,
        "tagGene" : false,
        "type" : "haplotype"
      },
      "strength" : {
        "@id" : "https://www.pharmgkb.org/data/ontologyTerm/guidelineStrength/guidelineStrength:981501929",
        "@context" : "https://www.pharmgkb.org/jsonld/ontologyTerm.jsonld",
        "id" : 981501929,
        "src" : "guidelineStrength",
        "term" : "N/A",
        "termId" : "guidelineStrength:981501929"
      },
      "textHtml" : "<p>Cystic Fibrosis patient heterozygous for G551D-CFTR (<a href=\"/rsid/rs75527207\">rs75527207</a> genotype AG).</p>"
    }, {
      "id" : 1184135234,
      "diplotypeIds1" : [ "PA166117964", "PA166117963" ],
      "diplotypeIds2" : [ "PA166117964", "PA166117963" ],
      "drug" : {
        "objCls" : "Drug",
        "@id" : "https://www.pharmgkb.org/data/drug/PA165950341",
        "@context" : "https://www.pharmgkb.org/jsonld/drug.jsonld",
        "id" : "PA165950341",
        "name" : "ivacaftor"
      },
      "groups" : [ {
        "@id" : "https://www.pharmgkb.org/data/ontologyTerm/guidelineTags/guidelineTags:981501927",
        "@context" : "https://www.pharmgkb.org/jsonld/ontologyTerm.jsonld",
        "id" : 981501927,
        "src" : "guidelineTags",
        "term" : "Phenotype (Genotype)",
        "termId" : "guidelineTags:981501927"
      } ],
      "location" : {
        "id" : 1184135241,
        "copyNumber" : "1",
        "diplotypes" : [ {
          "id" : 1184135245,
          "allele1" : "F508del(CTT)",
          "allele2" : "F508del(CTT)"
        }, {
          "id" : 1184135244,
          "allele1" : "F508del(CTT)",
          "allele2" : "F508del(TCT)"
        }, {
          "id" : 1184135243,
          "allele1" : "F508del(TCT)",
          "allele2" : "F508del(CTT)"
        }, {
          "id" : 1184135242,
          "allele1" : "F508del(TCT)",
          "allele2" : "F508del(TCT)"
        } ],
        "displayName" : "CFTR F508del(CTT), CFTR F508del(TCT)",
        "genes" : [ {
          "objCls" : "Gene",
          "@id" : "https://www.pharmgkb.org/data/gene/PA109",
          "@context" : "https://www.pharmgkb.org/jsonld/gene.jsonld",
          "id" : "PA109",
          "symbol" : "CFTR",
          "name" : "cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7)"
        } ],
        "gpPosition" : -1,
        "haplotypes" : [ {
          "objCls" : "Haplotype",
          "@id" : "https://www.pharmgkb.org/data/haplotype/PA166117963",
          "@context" : "https://www.pharmgkb.org/jsonld/haplotype.jsonld",
          "id" : "PA166117963",
          "name" : "F508del(CTT)"
        }, {
          "objCls" : "Haplotype",
          "@id" : "https://www.pharmgkb.org/data/haplotype/PA166117964",
          "@context" : "https://www.pharmgkb.org/jsonld/haplotype.jsonld",
          "id" : "PA166117964",
          "name" : "F508del(TCT)"
        } ],
        "refSeqPosition" : -1,
        "tagGene" : false,
        "type" : "haplotype"
      },
      "strength" : {
        "@id" : "https://www.pharmgkb.org/data/ontologyTerm/guidelineStrength/guidelineStrength:981501929",
        "@context" : "https://www.pharmgkb.org/jsonld/ontologyTerm.jsonld",
        "id" : 981501929,
        "src" : "guidelineStrength",
        "term" : "N/A",
        "termId" : "guidelineStrength:981501929"
      },
      "textHtml" : "<p>Cystic Fibrosis patient homozygous for F508del-CFTR, <a href=\"/rsid/rs113993960\">rs113993960</a> or <a href=\"/rsid/rs199826652\">rs199826652</a> genotype del/del. </p>"
    }, {
      "id" : 1184137026,
      "diplotypeIds1" : [ "PA166117965" ],
      "diplotypeIds2" : [ "PA166117966", "PA166117967", "PA166117968", "PA166117969", "PA166117970", "PA166117971", "PA166117972", "PA166117973", "PA166117974" ],
      "drug" : {
        "objCls" : "Drug",
        "@id" : "https://www.pharmgkb.org/data/drug/PA165950341",
        "@context" : "https://www.pharmgkb.org/jsonld/drug.jsonld",
        "id" : "PA165950341",
        "name" : "ivacaftor"
      },
      "groups" : [ {
        "@id" : "https://www.pharmgkb.org/data/ontologyTerm/guidelineTags/guidelineTags:981501927",
        "@context" : "https://www.pharmgkb.org/jsonld/ontologyTerm.jsonld",
        "id" : 981501927,
        "src" : "guidelineTags",
        "term" : "Phenotype (Genotype)",
        "termId" : "guidelineTags:981501927"
      } ],
      "location" : {
        "id" : 1184137016,
        "copyNumber" : "1",
        "diplotypes" : [ {
          "id" : 1184137018,
          "allele1" : "G551D",
          "allele2" : "G1244E"
        }, {
          "id" : 1184137017,
          "allele1" : "G551D",
          "allele2" : "G1349D"
        }, {
          "id" : 1184137020,
          "allele1" : "G551D",
          "allele2" : "G178R"
        }, {
          "id" : 1184137019,
          "allele1" : "G551D",
          "allele2" : "G551S"
        }, {
          "id" : 1184137021,
          "allele1" : "G551D",
          "allele2" : "S1251N"
        }, {
          "id" : 1184137024,
          "allele1" : "G551D",
          "allele2" : "S1255P"
        }, {
          "id" : 1184137025,
          "allele1" : "G551D",
          "allele2" : "S549N"
        }, {
          "id" : 1184137022,
          "allele1" : "G551D",
          "allele2" : "S549R(A>C)"
        }, {
          "id" : 1184137023,
          "allele1" : "G551D",
          "allele2" : "S549R(T>G)"
        } ],
        "displayName" : "CFTR G1244E, CFTR G1349D, CFTR G178R, CFTR G551D, CFTR G551S, CFTR S1251N, CFTR S1255P, CFTR S549N, CFTR S549R(A>C), CFTR S549R(T>G)",
        "genes" : [ {
          "objCls" : "Gene",
          "@id" : "https://www.pharmgkb.org/data/gene/PA109",
          "@context" : "https://www.pharmgkb.org/jsonld/gene.jsonld",
          "id" : "PA109",
          "symbol" : "CFTR",
          "name" : "cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7)"
        } ],
        "gpPosition" : -1,
        "haplotypes" : [ {
          "objCls" : "Haplotype",
          "@id" : "https://www.pharmgkb.org/data/haplotype/PA166117966",
          "@context" : "https://www.pharmgkb.org/jsonld/haplotype.jsonld",
          "id" : "PA166117966",
          "name" : "G1244E"
        }, {
          "objCls" : "Haplotype",
          "@id" : "https://www.pharmgkb.org/data/haplotype/PA166117967",
          "@context" : "https://www.pharmgkb.org/jsonld/haplotype.jsonld",
          "id" : "PA166117967",
          "name" : "G1349D"
        }, {
          "objCls" : "Haplotype",
          "@id" : "https://www.pharmgkb.org/data/haplotype/PA166117968",
          "@context" : "https://www.pharmgkb.org/jsonld/haplotype.jsonld",
          "id" : "PA166117968",
          "name" : "G178R"
        }, {
          "objCls" : "Haplotype",
          "@id" : "https://www.pharmgkb.org/data/haplotype/PA166117965",
          "@context" : "https://www.pharmgkb.org/jsonld/haplotype.jsonld",
          "id" : "PA166117965",
          "name" : "G551D"
        }, {
          "objCls" : "Haplotype",
          "@id" : "https://www.pharmgkb.org/data/haplotype/PA166117969",
          "@context" : "https://www.pharmgkb.org/jsonld/haplotype.jsonld",
          "id" : "PA166117969",
          "name" : "G551S"
        }, {
          "objCls" : "Haplotype",
          "@id" : "https://www.pharmgkb.org/data/haplotype/PA166117970",
          "@context" : "https://www.pharmgkb.org/jsonld/haplotype.jsonld",
          "id" : "PA166117970",
          "name" : "S1251N"
        }, {
          "objCls" : "Haplotype",
          "@id" : "https://www.pharmgkb.org/data/haplotype/PA166117971",
          "@context" : "https://www.pharmgkb.org/jsonld/haplotype.jsonld",
          "id" : "PA166117971",
          "name" : "S1255P"
        }, {
          "objCls" : "Haplotype",
          "@id" : "https://www.pharmgkb.org/data/haplotype/PA166117972",
          "@context" : "https://www.pharmgkb.org/jsonld/haplotype.jsonld",
          "id" : "PA166117972",
          "name" : "S549N"
        }, {
          "objCls" : "Haplotype",
          "@id" : "https://www.pharmgkb.org/data/haplotype/PA166117973",
          "@context" : "https://www.pharmgkb.org/jsonld/haplotype.jsonld",
          "id" : "PA166117973",
          "name" : "S549R(A>C)"
        }, {
          "objCls" : "Haplotype",
          "@id" : "https://www.pharmgkb.org/data/haplotype/PA166117974",
          "@context" : "https://www.pharmgkb.org/jsonld/haplotype.jsonld",
          "id" : "PA166117974",
          "name" : "S549R(T>G)"
        } ],
        "refSeqPosition" : -1,
        "tagGene" : false,
        "type" : "haplotype"
      },
      "strength" : {
        "@id" : "https://www.pharmgkb.org/data/ontologyTerm/guidelineStrength/guidelineStrength:981501929",
        "@context" : "https://www.pharmgkb.org/jsonld/ontologyTerm.jsonld",
        "id" : 981501929,
        "src" : "guidelineStrength",
        "term" : "N/A",
        "termId" : "guidelineStrength:981501929"
      },
      "textHtml" : "<p>Cystic Fibrosis patient heterozygous for G551D-CFTR (<a href=\"/rsid/rs75527207\">rs75527207</a> genotype AG).</p>"
    }, {
      "id" : 1184135204,
      "diplotypeIds1" : [ "PA166117966", "PA166117967", "PA166117968", "PA166117969", "PA166117970", "PA166117971", "PA166117972", "PA166117973", "PA166117974" ],
      "diplotypeIds2" : [ null ],
      "drug" : {
        "objCls" : "Drug",
        "@id" : "https://www.pharmgkb.org/data/drug/PA165950341",
        "@context" : "https://www.pharmgkb.org/jsonld/drug.jsonld",
        "id" : "PA165950341",
        "name" : "ivacaftor"
      },
      "groups" : [ {
        "@id" : "https://www.pharmgkb.org/data/ontologyTerm/guidelineTags/guidelineTags:981501927",
        "@context" : "https://www.pharmgkb.org/jsonld/ontologyTerm.jsonld",
        "id" : 981501927,
        "src" : "guidelineTags",
        "term" : "Phenotype (Genotype)",
        "termId" : "guidelineTags:981501927"
      } ],
      "location" : {
        "id" : 1184137177,
        "copyNumber" : "1",
        "diplotypes" : [ {
          "id" : 1184137178,
          "allele1" : "G1244E"
        }, {
          "id" : 1184137179,
          "allele1" : "G1349D"
        }, {
          "id" : 1184137180,
          "allele1" : "G178R"
        }, {
          "id" : 1184137181,
          "allele1" : "G551S"
        }, {
          "id" : 1184137182,
          "allele1" : "S1251N"
        }, {
          "id" : 1184137183,
          "allele1" : "S1255P"
        }, {
          "id" : 1184137184,
          "allele1" : "S549N"
        }, {
          "id" : 1184137185,
          "allele1" : "S549R(A>C)"
        }, {
          "id" : 1184137186,
          "allele1" : "S549R(T>G)"
        } ],
        "displayName" : "CFTR G1244E, CFTR G1349D, CFTR G178R, CFTR G551S, CFTR S1251N, CFTR S1255P, CFTR S549N, CFTR S549R(A>C), CFTR S549R(T>G)",
        "genes" : [ {
          "objCls" : "Gene",
          "@id" : "https://www.pharmgkb.org/data/gene/PA109",
          "@context" : "https://www.pharmgkb.org/jsonld/gene.jsonld",
          "id" : "PA109",
          "symbol" : "CFTR",
          "name" : "cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7)"
        } ],
        "gpPosition" : -1,
        "haplotypes" : [ {
          "objCls" : "Haplotype",
          "@id" : "https://www.pharmgkb.org/data/haplotype/PA166117966",
          "@context" : "https://www.pharmgkb.org/jsonld/haplotype.jsonld",
          "id" : "PA166117966",
          "name" : "G1244E"
        }, {
          "objCls" : "Haplotype",
          "@id" : "https://www.pharmgkb.org/data/haplotype/PA166117967",
          "@context" : "https://www.pharmgkb.org/jsonld/haplotype.jsonld",
          "id" : "PA166117967",
          "name" : "G1349D"
        }, {
          "objCls" : "Haplotype",
          "@id" : "https://www.pharmgkb.org/data/haplotype/PA166117968",
          "@context" : "https://www.pharmgkb.org/jsonld/haplotype.jsonld",
          "id" : "PA166117968",
          "name" : "G178R"
        }, {
          "objCls" : "Haplotype",
          "@id" : "https://www.pharmgkb.org/data/haplotype/PA166117969",
          "@context" : "https://www.pharmgkb.org/jsonld/haplotype.jsonld",
          "id" : "PA166117969",
          "name" : "G551S"
        }, {
          "objCls" : "Haplotype",
          "@id" : "https://www.pharmgkb.org/data/haplotype/PA166117970",
          "@context" : "https://www.pharmgkb.org/jsonld/haplotype.jsonld",
          "id" : "PA166117970",
          "name" : "S1251N"
        }, {
          "objCls" : "Haplotype",
          "@id" : "https://www.pharmgkb.org/data/haplotype/PA166117971",
          "@context" : "https://www.pharmgkb.org/jsonld/haplotype.jsonld",
          "id" : "PA166117971",
          "name" : "S1255P"
        }, {
          "objCls" : "Haplotype",
          "@id" : "https://www.pharmgkb.org/data/haplotype/PA166117972",
          "@context" : "https://www.pharmgkb.org/jsonld/haplotype.jsonld",
          "id" : "PA166117972",
          "name" : "S549N"
        }, {
          "objCls" : "Haplotype",
          "@id" : "https://www.pharmgkb.org/data/haplotype/PA166117973",
          "@context" : "https://www.pharmgkb.org/jsonld/haplotype.jsonld",
          "id" : "PA166117973",
          "name" : "S549R(A>C)"
        }, {
          "objCls" : "Haplotype",
          "@id" : "https://www.pharmgkb.org/data/haplotype/PA166117974",
          "@context" : "https://www.pharmgkb.org/jsonld/haplotype.jsonld",
          "id" : "PA166117974",
          "name" : "S549R(T>G)"
        } ],
        "refSeqPosition" : -1,
        "tagGene" : false,
        "type" : "haplotype"
      },
      "strength" : {
        "@id" : "https://www.pharmgkb.org/data/ontologyTerm/guidelineStrength/guidelineStrength:981501929",
        "@context" : "https://www.pharmgkb.org/jsonld/ontologyTerm.jsonld",
        "id" : 981501929,
        "src" : "guidelineStrength",
        "term" : "N/A",
        "termId" : "guidelineStrength:981501929"
      },
      "textHtml" : "<p>Cystic Fibrosis patient with at least one CFTR gating variant.</p>"
    }, {
      "id" : 1183698549,
      "diplotypeIds1" : [ "PA166117965" ],
      "diplotypeIds2" : [ "PA166117965" ],
      "drug" : {
        "objCls" : "Drug",
        "@id" : "https://www.pharmgkb.org/data/drug/PA165950341",
        "@context" : "https://www.pharmgkb.org/jsonld/drug.jsonld",
        "id" : "PA165950341",
        "name" : "ivacaftor"
      },
      "groups" : [ {
        "@id" : "https://www.pharmgkb.org/data/ontologyTerm/guidelineTags/guidelineTags:981501925",
        "@context" : "https://www.pharmgkb.org/jsonld/ontologyTerm.jsonld",
        "id" : 981501925,
        "src" : "guidelineTags",
        "term" : "Implications",
        "termId" : "guidelineTags:981501925"
      } ],
      "location" : {
        "id" : 1184134921,
        "copyNumber" : "1",
        "diplotypes" : [ {
          "id" : 1184134922,
          "allele1" : "G551D",
          "allele2" : "G551D"
        } ],
        "displayName" : "CFTR G551D",
        "genes" : [ {
          "objCls" : "Gene",
          "@id" : "https://www.pharmgkb.org/data/gene/PA109",
          "@context" : "https://www.pharmgkb.org/jsonld/gene.jsonld",
          "id" : "PA109",
          "symbol" : "CFTR",
          "name" : "cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7)"
        } ],
        "gpPosition" : -1,
        "haplotypes" : [ {
          "objCls" : "Haplotype",
          "@id" : "https://www.pharmgkb.org/data/haplotype/PA166117965",
          "@context" : "https://www.pharmgkb.org/jsonld/haplotype.jsonld",
          "id" : "PA166117965",
          "name" : "G551D"
        } ],
        "refSeqPosition" : -1,
        "tagGene" : false,
        "type" : "haplotype"
      },
      "strength" : {
        "@id" : "https://www.pharmgkb.org/data/ontologyTerm/guidelineStrength/guidelineStrength:981501929",
        "@context" : "https://www.pharmgkb.org/jsonld/ontologyTerm.jsonld",
        "id" : 981501929,
        "src" : "guidelineStrength",
        "term" : "N/A",
        "termId" : "guidelineStrength:981501929"
      },
      "textHtml" : "<p>Significant improvement in lung function, weight, risk of pulmonary exacerbation, patient reported outcomes, and reduction in sweat chloride concentrations through enhanced CFTR channel activity (increased probability of open channel).</p>"
    }, {
      "id" : 1183698558,
      "diplotypeIds1" : [ "PA166117965" ],
      "diplotypeIds2" : [ null ],
      "drug" : {
        "objCls" : "Drug",
        "@id" : "https://www.pharmgkb.org/data/drug/PA165950341",
        "@context" : "https://www.pharmgkb.org/jsonld/drug.jsonld",
        "id" : "PA165950341",
        "name" : "ivacaftor"
      },
      "groups" : [ {
        "@id" : "https://www.pharmgkb.org/data/ontologyTerm/guidelineTags/guidelineTags:981501925",
        "@context" : "https://www.pharmgkb.org/jsonld/ontologyTerm.jsonld",
        "id" : 981501925,
        "src" : "guidelineTags",
        "term" : "Implications",
        "termId" : "guidelineTags:981501925"
      } ],
      "location" : {
        "id" : 1184134927,
        "copyNumber" : "1",
        "diplotypes" : [ {
          "id" : 1184134928,
          "allele1" : "G551D"
        } ],
        "displayName" : "CFTR G551D",
        "genes" : [ {
          "objCls" : "Gene",
          "@id" : "https://www.pharmgkb.org/data/gene/PA109",
          "@context" : "https://www.pharmgkb.org/jsonld/gene.jsonld",
          "id" : "PA109",
          "symbol" : "CFTR",
          "name" : "cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7)"
        } ],
        "gpPosition" : -1,
        "haplotypes" : [ {
          "objCls" : "Haplotype",
          "@id" : "https://www.pharmgkb.org/data/haplotype/PA166117965",
          "@context" : "https://www.pharmgkb.org/jsonld/haplotype.jsonld",
          "id" : "PA166117965",
          "name" : "G551D"
        } ],
        "refSeqPosition" : -1,
        "tagGene" : false,
        "type" : "haplotype"
      },
      "strength" : {
        "@id" : "https://www.pharmgkb.org/data/ontologyTerm/guidelineStrength/guidelineStrength:981501929",
        "@context" : "https://www.pharmgkb.org/jsonld/ontologyTerm.jsonld",
        "id" : 981501929,
        "src" : "guidelineStrength",
        "term" : "N/A",
        "termId" : "guidelineStrength:981501929"
      },
      "textHtml" : "<p>Significant improvement in lung function, weight, risk of pulmonary exacerbation, patient reported outcomes, and reduction in sweat chloride concentrations through enhanced CFTR channel activity (increased probability of open channel).</p>"
    }, {
      "id" : 1184135237,
      "diplotypeIds1" : [ "PA166117964", "PA166117963" ],
      "diplotypeIds2" : [ "PA166117964", "PA166117963" ],
      "drug" : {
        "objCls" : "Drug",
        "@id" : "https://www.pharmgkb.org/data/drug/PA165950341",
        "@context" : "https://www.pharmgkb.org/jsonld/drug.jsonld",
        "id" : "PA165950341",
        "name" : "ivacaftor"
      },
      "groups" : [ {
        "@id" : "https://www.pharmgkb.org/data/ontologyTerm/guidelineTags/guidelineTags:981501925",
        "@context" : "https://www.pharmgkb.org/jsonld/ontologyTerm.jsonld",
        "id" : 981501925,
        "src" : "guidelineTags",
        "term" : "Implications",
        "termId" : "guidelineTags:981501925"
      } ],
      "location" : {
        "id" : 1184135251,
        "copyNumber" : "1",
        "diplotypes" : [ {
          "id" : 1184135255,
          "allele1" : "F508del(CTT)",
          "allele2" : "F508del(CTT)"
        }, {
          "id" : 1184135254,
          "allele1" : "F508del(CTT)",
          "allele2" : "F508del(TCT)"
        }, {
          "id" : 1184135253,
          "allele1" : "F508del(TCT)",
          "allele2" : "F508del(CTT)"
        }, {
          "id" : 1184135252,
          "allele1" : "F508del(TCT)",
          "allele2" : "F508del(TCT)"
        } ],
        "displayName" : "CFTR F508del(CTT), CFTR F508del(TCT)",
        "genes" : [ {
          "objCls" : "Gene",
          "@id" : "https://www.pharmgkb.org/data/gene/PA109",
          "@context" : "https://www.pharmgkb.org/jsonld/gene.jsonld",
          "id" : "PA109",
          "symbol" : "CFTR",
          "name" : "cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7)"
        } ],
        "gpPosition" : -1,
        "haplotypes" : [ {
          "objCls" : "Haplotype",
          "@id" : "https://www.pharmgkb.org/data/haplotype/PA166117963",
          "@context" : "https://www.pharmgkb.org/jsonld/haplotype.jsonld",
          "id" : "PA166117963",
          "name" : "F508del(CTT)"
        }, {
          "objCls" : "Haplotype",
          "@id" : "https://www.pharmgkb.org/data/haplotype/PA166117964",
          "@context" : "https://www.pharmgkb.org/jsonld/haplotype.jsonld",
          "id" : "PA166117964",
          "name" : "F508del(TCT)"
        } ],
        "refSeqPosition" : -1,
        "tagGene" : false,
        "type" : "haplotype"
      },
      "strength" : {
        "@id" : "https://www.pharmgkb.org/data/ontologyTerm/guidelineStrength/guidelineStrength:981501929",
        "@context" : "https://www.pharmgkb.org/jsonld/ontologyTerm.jsonld",
        "id" : 981501929,
        "src" : "guidelineStrength",
        "term" : "N/A",
        "termId" : "guidelineStrength:981501929"
      },
      "textHtml" : "<p>No significant reduction in sweat chloride concentrations; no changes in other clinical measurements including spirometric measurements, pulmonary exacerbations, or body weight. Unlikely to respond to treatment. </p><p><em>The recommendation for patients with the F508del/F508del genotype is based on ivacaftor mechanism of action and clinical observational data. The clinical study however was a safety study and was not powered to detect a difference in efficacy [Article:<a href=\"/pmid/22383668\">22383668</a>].</em></p>"
    }, {
      "id" : 1184137121,
      "diplotypeIds1" : [ "PA166117965" ],
      "diplotypeIds2" : [ "PA166117966", "PA166117967", "PA166117968", "PA166117969", "PA166117970", "PA166117971", "PA166117972", "PA166117973", "PA166117974" ],
      "drug" : {
        "objCls" : "Drug",
        "@id" : "https://www.pharmgkb.org/data/drug/PA165950341",
        "@context" : "https://www.pharmgkb.org/jsonld/drug.jsonld",
        "id" : "PA165950341",
        "name" : "ivacaftor"
      },
      "groups" : [ {
        "@id" : "https://www.pharmgkb.org/data/ontologyTerm/guidelineTags/guidelineTags:981501925",
        "@context" : "https://www.pharmgkb.org/jsonld/ontologyTerm.jsonld",
        "id" : 981501925,
        "src" : "guidelineTags",
        "term" : "Implications",
        "termId" : "guidelineTags:981501925"
      } ],
      "location" : {
        "id" : 1184137111,
        "copyNumber" : "1",
        "diplotypes" : [ {
          "id" : 1184137113,
          "allele1" : "G551D",
          "allele2" : "G1244E"
        }, {
          "id" : 1184137112,
          "allele1" : "G551D",
          "allele2" : "G1349D"
        }, {
          "id" : 1184137115,
          "allele1" : "G551D",
          "allele2" : "G178R"
        }, {
          "id" : 1184137114,
          "allele1" : "G551D",
          "allele2" : "G551S"
        }, {
          "id" : 1184137116,
          "allele1" : "G551D",
          "allele2" : "S1251N"
        }, {
          "id" : 1184137119,
          "allele1" : "G551D",
          "allele2" : "S1255P"
        }, {
          "id" : 1184137120,
          "allele1" : "G551D",
          "allele2" : "S549N"
        }, {
          "id" : 1184137117,
          "allele1" : "G551D",
          "allele2" : "S549R(A>C)"
        }, {
          "id" : 1184137118,
          "allele1" : "G551D",
          "allele2" : "S549R(T>G)"
        } ],
        "displayName" : "CFTR G1244E, CFTR G1349D, CFTR G178R, CFTR G551D, CFTR G551S, CFTR S1251N, CFTR S1255P, CFTR S549N, CFTR S549R(A>C), CFTR S549R(T>G)",
        "genes" : [ {
          "objCls" : "Gene",
          "@id" : "https://www.pharmgkb.org/data/gene/PA109",
          "@context" : "https://www.pharmgkb.org/jsonld/gene.jsonld",
          "id" : "PA109",
          "symbol" : "CFTR",
          "name" : "cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7)"
        } ],
        "gpPosition" : -1,
        "haplotypes" : [ {
          "objCls" : "Haplotype",
          "@id" : "https://www.pharmgkb.org/data/haplotype/PA166117966",
          "@context" : "https://www.pharmgkb.org/jsonld/haplotype.jsonld",
          "id" : "PA166117966",
          "name" : "G1244E"
        }, {
          "objCls" : "Haplotype",
          "@id" : "https://www.pharmgkb.org/data/haplotype/PA166117967",
          "@context" : "https://www.pharmgkb.org/jsonld/haplotype.jsonld",
          "id" : "PA166117967",
          "name" : "G1349D"
        }, {
          "objCls" : "Haplotype",
          "@id" : "https://www.pharmgkb.org/data/haplotype/PA166117968",
          "@context" : "https://www.pharmgkb.org/jsonld/haplotype.jsonld",
          "id" : "PA166117968",
          "name" : "G178R"
        }, {
          "objCls" : "Haplotype",
          "@id" : "https://www.pharmgkb.org/data/haplotype/PA166117965",
          "@context" : "https://www.pharmgkb.org/jsonld/haplotype.jsonld",
          "id" : "PA166117965",
          "name" : "G551D"
        }, {
          "objCls" : "Haplotype",
          "@id" : "https://www.pharmgkb.org/data/haplotype/PA166117969",
          "@context" : "https://www.pharmgkb.org/jsonld/haplotype.jsonld",
          "id" : "PA166117969",
          "name" : "G551S"
        }, {
          "objCls" : "Haplotype",
          "@id" : "https://www.pharmgkb.org/data/haplotype/PA166117970",
          "@context" : "https://www.pharmgkb.org/jsonld/haplotype.jsonld",
          "id" : "PA166117970",
          "name" : "S1251N"
        }, {
          "objCls" : "Haplotype",
          "@id" : "https://www.pharmgkb.org/data/haplotype/PA166117971",
          "@context" : "https://www.pharmgkb.org/jsonld/haplotype.jsonld",
          "id" : "PA166117971",
          "name" : "S1255P"
        }, {
          "objCls" : "Haplotype",
          "@id" : "https://www.pharmgkb.org/data/haplotype/PA166117972",
          "@context" : "https://www.pharmgkb.org/jsonld/haplotype.jsonld",
          "id" : "PA166117972",
          "name" : "S549N"
        }, {
          "objCls" : "Haplotype",
          "@id" : "https://www.pharmgkb.org/data/haplotype/PA166117973",
          "@context" : "https://www.pharmgkb.org/jsonld/haplotype.jsonld",
          "id" : "PA166117973",
          "name" : "S549R(A>C)"
        }, {
          "objCls" : "Haplotype",
          "@id" : "https://www.pharmgkb.org/data/haplotype/PA166117974",
          "@context" : "https://www.pharmgkb.org/jsonld/haplotype.jsonld",
          "id" : "PA166117974",
          "name" : "S549R(T>G)"
        } ],
        "refSeqPosition" : -1,
        "tagGene" : false,
        "type" : "haplotype"
      },
      "strength" : {
        "@id" : "https://www.pharmgkb.org/data/ontologyTerm/guidelineStrength/guidelineStrength:981501929",
        "@context" : "https://www.pharmgkb.org/jsonld/ontologyTerm.jsonld",
        "id" : 981501929,
        "src" : "guidelineStrength",
        "term" : "N/A",
        "termId" : "guidelineStrength:981501929"
      },
      "textHtml" : "<p>Significant improvement in lung function, weight, risk of pulmonary exacerbation, patient reported outcomes, and reduction in sweat chloride concentrations through enhanced CFTR channel activity (increased probability of open channel).</p>"
    }, {
      "id" : 1184135215,
      "diplotypeIds1" : [ "PA166117966", "PA166117967", "PA166117968", "PA166117969", "PA166117970", "PA166117971", "PA166117972", "PA166117973", "PA166117974" ],
      "diplotypeIds2" : [ null ],
      "drug" : {
        "objCls" : "Drug",
        "@id" : "https://www.pharmgkb.org/data/drug/PA165950341",
        "@context" : "https://www.pharmgkb.org/jsonld/drug.jsonld",
        "id" : "PA165950341",
        "name" : "ivacaftor"
      },
      "groups" : [ {
        "@id" : "https://www.pharmgkb.org/data/ontologyTerm/guidelineTags/guidelineTags:981501925",
        "@context" : "https://www.pharmgkb.org/jsonld/ontologyTerm.jsonld",
        "id" : 981501925,
        "src" : "guidelineTags",
        "term" : "Implications",
        "termId" : "guidelineTags:981501925"
      } ],
      "location" : {
        "id" : 1184137197,
        "copyNumber" : "1",
        "diplotypes" : [ {
          "id" : 1184137198,
          "allele1" : "G1244E"
        }, {
          "id" : 1184137199,
          "allele1" : "G1349D"
        }, {
          "id" : 1184137200,
          "allele1" : "G178R"
        }, {
          "id" : 1184137201,
          "allele1" : "G551S"
        }, {
          "id" : 1184137202,
          "allele1" : "S1251N"
        }, {
          "id" : 1184137203,
          "allele1" : "S1255P"
        }, {
          "id" : 1184137204,
          "allele1" : "S549N"
        }, {
          "id" : 1184137205,
          "allele1" : "S549R(A>C)"
        }, {
          "id" : 1184137206,
          "allele1" : "S549R(T>G)"
        } ],
        "displayName" : "CFTR G1244E, CFTR G1349D, CFTR G178R, CFTR G551S, CFTR S1251N, CFTR S1255P, CFTR S549N, CFTR S549R(A>C), CFTR S549R(T>G)",
        "genes" : [ {
          "objCls" : "Gene",
          "@id" : "https://www.pharmgkb.org/data/gene/PA109",
          "@context" : "https://www.pharmgkb.org/jsonld/gene.jsonld",
          "id" : "PA109",
          "symbol" : "CFTR",
          "name" : "cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7)"
        } ],
        "gpPosition" : -1,
        "haplotypes" : [ {
          "objCls" : "Haplotype",
          "@id" : "https://www.pharmgkb.org/data/haplotype/PA166117966",
          "@context" : "https://www.pharmgkb.org/jsonld/haplotype.jsonld",
          "id" : "PA166117966",
          "name" : "G1244E"
        }, {
          "objCls" : "Haplotype",
          "@id" : "https://www.pharmgkb.org/data/haplotype/PA166117967",
          "@context" : "https://www.pharmgkb.org/jsonld/haplotype.jsonld",
          "id" : "PA166117967",
          "name" : "G1349D"
        }, {
          "objCls" : "Haplotype",
          "@id" : "https://www.pharmgkb.org/data/haplotype/PA166117968",
          "@context" : "https://www.pharmgkb.org/jsonld/haplotype.jsonld",
          "id" : "PA166117968",
          "name" : "G178R"
        }, {
          "objCls" : "Haplotype",
          "@id" : "https://www.pharmgkb.org/data/haplotype/PA166117969",
          "@context" : "https://www.pharmgkb.org/jsonld/haplotype.jsonld",
          "id" : "PA166117969",
          "name" : "G551S"
        }, {
          "objCls" : "Haplotype",
          "@id" : "https://www.pharmgkb.org/data/haplotype/PA166117970",
          "@context" : "https://www.pharmgkb.org/jsonld/haplotype.jsonld",
          "id" : "PA166117970",
          "name" : "S1251N"
        }, {
          "objCls" : "Haplotype",
          "@id" : "https://www.pharmgkb.org/data/haplotype/PA166117971",
          "@context" : "https://www.pharmgkb.org/jsonld/haplotype.jsonld",
          "id" : "PA166117971",
          "name" : "S1255P"
        }, {
          "objCls" : "Haplotype",
          "@id" : "https://www.pharmgkb.org/data/haplotype/PA166117972",
          "@context" : "https://www.pharmgkb.org/jsonld/haplotype.jsonld",
          "id" : "PA166117972",
          "name" : "S549N"
        }, {
          "objCls" : "Haplotype",
          "@id" : "https://www.pharmgkb.org/data/haplotype/PA166117973",
          "@context" : "https://www.pharmgkb.org/jsonld/haplotype.jsonld",
          "id" : "PA166117973",
          "name" : "S549R(A>C)"
        }, {
          "objCls" : "Haplotype",
          "@id" : "https://www.pharmgkb.org/data/haplotype/PA166117974",
          "@context" : "https://www.pharmgkb.org/jsonld/haplotype.jsonld",
          "id" : "PA166117974",
          "name" : "S549R(T>G)"
        } ],
        "refSeqPosition" : -1,
        "tagGene" : false,
        "type" : "haplotype"
      },
      "strength" : {
        "@id" : "https://www.pharmgkb.org/data/ontologyTerm/guidelineStrength/guidelineStrength:981501929",
        "@context" : "https://www.pharmgkb.org/jsonld/ontologyTerm.jsonld",
        "id" : 981501929,
        "src" : "guidelineStrength",
        "term" : "N/A",
        "termId" : "guidelineStrength:981501929"
      },
      "textHtml" : "<p>Significantly enhanced channel open probability <em>in vitro</em>. </p>"
    }, {
      "id" : 1183698552,
      "diplotypeIds1" : [ "PA166117965" ],
      "diplotypeIds2" : [ "PA166117965" ],
      "drug" : {
        "objCls" : "Drug",
        "@id" : "https://www.pharmgkb.org/data/drug/PA165950341",
        "@context" : "https://www.pharmgkb.org/jsonld/drug.jsonld",
        "id" : "PA165950341",
        "name" : "ivacaftor"
      },
      "groups" : [ {
        "@id" : "https://www.pharmgkb.org/data/ontologyTerm/guidelineTags/guidelineTags:981501928",
        "@context" : "https://www.pharmgkb.org/jsonld/ontologyTerm.jsonld",
        "id" : 981501928,
        "src" : "guidelineTags",
        "term" : "Recommendations",
        "termId" : "guidelineTags:981501928"
      } ],
      "location" : {
        "id" : 1184134923,
        "copyNumber" : "1",
        "diplotypes" : [ {
          "id" : 1184134924,
          "allele1" : "G551D",
          "allele2" : "G551D"
        } ],
        "displayName" : "CFTR G551D",
        "genes" : [ {
          "objCls" : "Gene",
          "@id" : "https://www.pharmgkb.org/data/gene/PA109",
          "@context" : "https://www.pharmgkb.org/jsonld/gene.jsonld",
          "id" : "PA109",
          "symbol" : "CFTR",
          "name" : "cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7)"
        } ],
        "gpPosition" : -1,
        "haplotypes" : [ {
          "objCls" : "Haplotype",
          "@id" : "https://www.pharmgkb.org/data/haplotype/PA166117965",
          "@context" : "https://www.pharmgkb.org/jsonld/haplotype.jsonld",
          "id" : "PA166117965",
          "name" : "G551D"
        } ],
        "refSeqPosition" : -1,
        "tagGene" : false,
        "type" : "haplotype"
      },
      "strength" : {
        "@id" : "https://www.pharmgkb.org/data/ontologyTerm/guidelineStrength/guidelineStrength:981501930",
        "@context" : "https://www.pharmgkb.org/jsonld/ontologyTerm.jsonld",
        "id" : 981501930,
        "src" : "guidelineStrength",
        "term" : "Strong",
        "termId" : "guidelineStrength:981501930"
      },
      "textHtml" : "<p>Use ivacaftor according to the product label (e.g., 150 mg every 12 hours for patients age 6 and older without other diseases; modify dose in patients with hepatic impairment).</p>"
    }, {
      "id" : 1183698561,
      "diplotypeIds1" : [ "PA166117965" ],
      "diplotypeIds2" : [ null ],
      "drug" : {
        "objCls" : "Drug",
        "@id" : "https://www.pharmgkb.org/data/drug/PA165950341",
        "@context" : "https://www.pharmgkb.org/jsonld/drug.jsonld",
        "id" : "PA165950341",
        "name" : "ivacaftor"
      },
      "groups" : [ {
        "@id" : "https://www.pharmgkb.org/data/ontologyTerm/guidelineTags/guidelineTags:981501928",
        "@context" : "https://www.pharmgkb.org/jsonld/ontologyTerm.jsonld",
        "id" : 981501928,
        "src" : "guidelineTags",
        "term" : "Recommendations",
        "termId" : "guidelineTags:981501928"
      } ],
      "location" : {
        "id" : 1184134929,
        "copyNumber" : "1",
        "diplotypes" : [ {
          "id" : 1184134930,
          "allele1" : "G551D"
        } ],
        "displayName" : "CFTR G551D",
        "genes" : [ {
          "objCls" : "Gene",
          "@id" : "https://www.pharmgkb.org/data/gene/PA109",
          "@context" : "https://www.pharmgkb.org/jsonld/gene.jsonld",
          "id" : "PA109",
          "symbol" : "CFTR",
          "name" : "cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7)"
        } ],
        "gpPosition" : -1,
        "haplotypes" : [ {
          "objCls" : "Haplotype",
          "@id" : "https://www.pharmgkb.org/data/haplotype/PA166117965",
          "@context" : "https://www.pharmgkb.org/jsonld/haplotype.jsonld",
          "id" : "PA166117965",
          "name" : "G551D"
        } ],
        "refSeqPosition" : -1,
        "tagGene" : false,
        "type" : "haplotype"
      },
      "strength" : {
        "@id" : "https://www.pharmgkb.org/data/ontologyTerm/guidelineStrength/guidelineStrength:981501930",
        "@context" : "https://www.pharmgkb.org/jsonld/ontologyTerm.jsonld",
        "id" : 981501930,
        "src" : "guidelineStrength",
        "term" : "Strong",
        "termId" : "guidelineStrength:981501930"
      },
      "textHtml" : "<p>Use ivacaftor according to the product label (e.g., 150 mg every 12 hours for patients age 6 and older without other diseases; modify dose in patients with hepatic impairment).</p>"
    }, {
      "id" : 1184135240,
      "diplotypeIds1" : [ "PA166117964", "PA166117963" ],
      "diplotypeIds2" : [ "PA166117964", "PA166117963" ],
      "drug" : {
        "objCls" : "Drug",
        "@id" : "https://www.pharmgkb.org/data/drug/PA165950341",
        "@context" : "https://www.pharmgkb.org/jsonld/drug.jsonld",
        "id" : "PA165950341",
        "name" : "ivacaftor"
      },
      "groups" : [ {
        "@id" : "https://www.pharmgkb.org/data/ontologyTerm/guidelineTags/guidelineTags:981501928",
        "@context" : "https://www.pharmgkb.org/jsonld/ontologyTerm.jsonld",
        "id" : 981501928,
        "src" : "guidelineTags",
        "term" : "Recommendations",
        "termId" : "guidelineTags:981501928"
      } ],
      "location" : {
        "id" : 1184135246,
        "copyNumber" : "1",
        "diplotypes" : [ {
          "id" : 1184135250,
          "allele1" : "F508del(CTT)",
          "allele2" : "F508del(CTT)"
        }, {
          "id" : 1184135249,
          "allele1" : "F508del(CTT)",
          "allele2" : "F508del(TCT)"
        }, {
          "id" : 1184135248,
          "allele1" : "F508del(TCT)",
          "allele2" : "F508del(CTT)"
        }, {
          "id" : 1184135247,
          "allele1" : "F508del(TCT)",
          "allele2" : "F508del(TCT)"
        } ],
        "displayName" : "CFTR F508del(CTT), CFTR F508del(TCT)",
        "genes" : [ {
          "objCls" : "Gene",
          "@id" : "https://www.pharmgkb.org/data/gene/PA109",
          "@context" : "https://www.pharmgkb.org/jsonld/gene.jsonld",
          "id" : "PA109",
          "symbol" : "CFTR",
          "name" : "cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7)"
        } ],
        "gpPosition" : -1,
        "haplotypes" : [ {
          "objCls" : "Haplotype",
          "@id" : "https://www.pharmgkb.org/data/haplotype/PA166117963",
          "@context" : "https://www.pharmgkb.org/jsonld/haplotype.jsonld",
          "id" : "PA166117963",
          "name" : "F508del(CTT)"
        }, {
          "objCls" : "Haplotype",
          "@id" : "https://www.pharmgkb.org/data/haplotype/PA166117964",
          "@context" : "https://www.pharmgkb.org/jsonld/haplotype.jsonld",
          "id" : "PA166117964",
          "name" : "F508del(TCT)"
        } ],
        "refSeqPosition" : -1,
        "tagGene" : false,
        "type" : "haplotype"
      },
      "strength" : {
        "@id" : "https://www.pharmgkb.org/data/ontologyTerm/guidelineStrength/guidelineStrength:981501931",
        "@context" : "https://www.pharmgkb.org/jsonld/ontologyTerm.jsonld",
        "id" : 981501931,
        "src" : "guidelineStrength",
        "term" : "Moderate",
        "termId" : "guidelineStrength:981501931"
      },
      "textHtml" : "<p>Ivacaftor is not recommended.</p><p><em>These recommendations are based on treatment of Cystic Fibrosis  patients with ivacaftor alone and current evidence. Clinical trials are currently underway to investigate ivacaftor alone or in combination with other drugs to treat Cystic Fibrosis patients with CFTR variants other than G551D, therefore there is potential that ivacaftor may be effective in these patients.</em></p>"
    }, {
      "id" : 1184137132,
      "diplotypeIds1" : [ "PA166117965" ],
      "diplotypeIds2" : [ "PA166117966", "PA166117967", "PA166117968", "PA166117969", "PA166117970", "PA166117971", "PA166117972", "PA166117973", "PA166117974" ],
      "drug" : {
        "objCls" : "Drug",
        "@id" : "https://www.pharmgkb.org/data/drug/PA165950341",
        "@context" : "https://www.pharmgkb.org/jsonld/drug.jsonld",
        "id" : "PA165950341",
        "name" : "ivacaftor"
      },
      "groups" : [ {
        "@id" : "https://www.pharmgkb.org/data/ontologyTerm/guidelineTags/guidelineTags:981501928",
        "@context" : "https://www.pharmgkb.org/jsonld/ontologyTerm.jsonld",
        "id" : 981501928,
        "src" : "guidelineTags",
        "term" : "Recommendations",
        "termId" : "guidelineTags:981501928"
      } ],
      "location" : {
        "id" : 1184137122,
        "copyNumber" : "1",
        "diplotypes" : [ {
          "id" : 1184137124,
          "allele1" : "G551D",
          "allele2" : "G1244E"
        }, {
          "id" : 1184137123,
          "allele1" : "G551D",
          "allele2" : "G1349D"
        }, {
          "id" : 1184137126,
          "allele1" : "G551D",
          "allele2" : "G178R"
        }, {
          "id" : 1184137125,
          "allele1" : "G551D",
          "allele2" : "G551S"
        }, {
          "id" : 1184137127,
          "allele1" : "G551D",
          "allele2" : "S1251N"
        }, {
          "id" : 1184137130,
          "allele1" : "G551D",
          "allele2" : "S1255P"
        }, {
          "id" : 1184137131,
          "allele1" : "G551D",
          "allele2" : "S549N"
        }, {
          "id" : 1184137128,
          "allele1" : "G551D",
          "allele2" : "S549R(A>C)"
        }, {
          "id" : 1184137129,
          "allele1" : "G551D",
          "allele2" : "S549R(T>G)"
        } ],
        "displayName" : "CFTR G1244E, CFTR G1349D, CFTR G178R, CFTR G551D, CFTR G551S, CFTR S1251N, CFTR S1255P, CFTR S549N, CFTR S549R(A>C), CFTR S549R(T>G)",
        "genes" : [ {
          "objCls" : "Gene",
          "@id" : "https://www.pharmgkb.org/data/gene/PA109",
          "@context" : "https://www.pharmgkb.org/jsonld/gene.jsonld",
          "id" : "PA109",
          "symbol" : "CFTR",
          "name" : "cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7)"
        } ],
        "gpPosition" : -1,
        "haplotypes" : [ {
          "objCls" : "Haplotype",
          "@id" : "https://www.pharmgkb.org/data/haplotype/PA166117966",
          "@context" : "https://www.pharmgkb.org/jsonld/haplotype.jsonld",
          "id" : "PA166117966",
          "name" : "G1244E"
        }, {
          "objCls" : "Haplotype",
          "@id" : "https://www.pharmgkb.org/data/haplotype/PA166117967",
          "@context" : "https://www.pharmgkb.org/jsonld/haplotype.jsonld",
          "id" : "PA166117967",
          "name" : "G1349D"
        }, {
          "objCls" : "Haplotype",
          "@id" : "https://www.pharmgkb.org/data/haplotype/PA166117968",
          "@context" : "https://www.pharmgkb.org/jsonld/haplotype.jsonld",
          "id" : "PA166117968",
          "name" : "G178R"
        }, {
          "objCls" : "Haplotype",
          "@id" : "https://www.pharmgkb.org/data/haplotype/PA166117965",
          "@context" : "https://www.pharmgkb.org/jsonld/haplotype.jsonld",
          "id" : "PA166117965",
          "name" : "G551D"
        }, {
          "objCls" : "Haplotype",
          "@id" : "https://www.pharmgkb.org/data/haplotype/PA166117969",
          "@context" : "https://www.pharmgkb.org/jsonld/haplotype.jsonld",
          "id" : "PA166117969",
          "name" : "G551S"
        }, {
          "objCls" : "Haplotype",
          "@id" : "https://www.pharmgkb.org/data/haplotype/PA166117970",
          "@context" : "https://www.pharmgkb.org/jsonld/haplotype.jsonld",
          "id" : "PA166117970",
          "name" : "S1251N"
        }, {
          "objCls" : "Haplotype",
          "@id" : "https://www.pharmgkb.org/data/haplotype/PA166117971",
          "@context" : "https://www.pharmgkb.org/jsonld/haplotype.jsonld",
          "id" : "PA166117971",
          "name" : "S1255P"
        }, {
          "objCls" : "Haplotype",
          "@id" : "https://www.pharmgkb.org/data/haplotype/PA166117972",
          "@context" : "https://www.pharmgkb.org/jsonld/haplotype.jsonld",
          "id" : "PA166117972",
          "name" : "S549N"
        }, {
          "objCls" : "Haplotype",
          "@id" : "https://www.pharmgkb.org/data/haplotype/PA166117973",
          "@context" : "https://www.pharmgkb.org/jsonld/haplotype.jsonld",
          "id" : "PA166117973",
          "name" : "S549R(A>C)"
        }, {
          "objCls" : "Haplotype",
          "@id" : "https://www.pharmgkb.org/data/haplotype/PA166117974",
          "@context" : "https://www.pharmgkb.org/jsonld/haplotype.jsonld",
          "id" : "PA166117974",
          "name" : "S549R(T>G)"
        } ],
        "refSeqPosition" : -1,
        "tagGene" : false,
        "type" : "haplotype"
      },
      "strength" : {
        "@id" : "https://www.pharmgkb.org/data/ontologyTerm/guidelineStrength/guidelineStrength:981501930",
        "@context" : "https://www.pharmgkb.org/jsonld/ontologyTerm.jsonld",
        "id" : 981501930,
        "src" : "guidelineStrength",
        "term" : "Strong",
        "termId" : "guidelineStrength:981501930"
      },
      "textHtml" : "<p>Use ivacaftor according to the product label (e.g., 150 mg every 12 hours for patients age 6 and older without other diseases; modify dose in patients with hepatic impairment).</p>"
    }, {
      "id" : 1184135228,
      "diplotypeIds1" : [ "PA166117966", "PA166117967", "PA166117968", "PA166117969", "PA166117970", "PA166117971", "PA166117972", "PA166117973", "PA166117974" ],
      "diplotypeIds2" : [ null ],
      "drug" : {
        "objCls" : "Drug",
        "@id" : "https://www.pharmgkb.org/data/drug/PA165950341",
        "@context" : "https://www.pharmgkb.org/jsonld/drug.jsonld",
        "id" : "PA165950341",
        "name" : "ivacaftor"
      },
      "groups" : [ {
        "@id" : "https://www.pharmgkb.org/data/ontologyTerm/guidelineTags/guidelineTags:981501928",
        "@context" : "https://www.pharmgkb.org/jsonld/ontologyTerm.jsonld",
        "id" : 981501928,
        "src" : "guidelineTags",
        "term" : "Recommendations",
        "termId" : "guidelineTags:981501928"
      } ],
      "location" : {
        "id" : 1184137187,
        "copyNumber" : "1",
        "diplotypes" : [ {
          "id" : 1184137188,
          "allele1" : "G1244E"
        }, {
          "id" : 1184137189,
          "allele1" : "G1349D"
        }, {
          "id" : 1184137190,
          "allele1" : "G178R"
        }, {
          "id" : 1184137191,
          "allele1" : "G551S"
        }, {
          "id" : 1184137192,
          "allele1" : "S1251N"
        }, {
          "id" : 1184137193,
          "allele1" : "S1255P"
        }, {
          "id" : 1184137194,
          "allele1" : "S549N"
        }, {
          "id" : 1184137195,
          "allele1" : "S549R(A>C)"
        }, {
          "id" : 1184137196,
          "allele1" : "S549R(T>G)"
        } ],
        "displayName" : "CFTR G1244E, CFTR G1349D, CFTR G178R, CFTR G551S, CFTR S1251N, CFTR S1255P, CFTR S549N, CFTR S549R(A>C), CFTR S549R(T>G)",
        "genes" : [ {
          "objCls" : "Gene",
          "@id" : "https://www.pharmgkb.org/data/gene/PA109",
          "@context" : "https://www.pharmgkb.org/jsonld/gene.jsonld",
          "id" : "PA109",
          "symbol" : "CFTR",
          "name" : "cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7)"
        } ],
        "gpPosition" : -1,
        "haplotypes" : [ {
          "objCls" : "Haplotype",
          "@id" : "https://www.pharmgkb.org/data/haplotype/PA166117966",
          "@context" : "https://www.pharmgkb.org/jsonld/haplotype.jsonld",
          "id" : "PA166117966",
          "name" : "G1244E"
        }, {
          "objCls" : "Haplotype",
          "@id" : "https://www.pharmgkb.org/data/haplotype/PA166117967",
          "@context" : "https://www.pharmgkb.org/jsonld/haplotype.jsonld",
          "id" : "PA166117967",
          "name" : "G1349D"
        }, {
          "objCls" : "Haplotype",
          "@id" : "https://www.pharmgkb.org/data/haplotype/PA166117968",
          "@context" : "https://www.pharmgkb.org/jsonld/haplotype.jsonld",
          "id" : "PA166117968",
          "name" : "G178R"
        }, {
          "objCls" : "Haplotype",
          "@id" : "https://www.pharmgkb.org/data/haplotype/PA166117969",
          "@context" : "https://www.pharmgkb.org/jsonld/haplotype.jsonld",
          "id" : "PA166117969",
          "name" : "G551S"
        }, {
          "objCls" : "Haplotype",
          "@id" : "https://www.pharmgkb.org/data/haplotype/PA166117970",
          "@context" : "https://www.pharmgkb.org/jsonld/haplotype.jsonld",
          "id" : "PA166117970",
          "name" : "S1251N"
        }, {
          "objCls" : "Haplotype",
          "@id" : "https://www.pharmgkb.org/data/haplotype/PA166117971",
          "@context" : "https://www.pharmgkb.org/jsonld/haplotype.jsonld",
          "id" : "PA166117971",
          "name" : "S1255P"
        }, {
          "objCls" : "Haplotype",
          "@id" : "https://www.pharmgkb.org/data/haplotype/PA166117972",
          "@context" : "https://www.pharmgkb.org/jsonld/haplotype.jsonld",
          "id" : "PA166117972",
          "name" : "S549N"
        }, {
          "objCls" : "Haplotype",
          "@id" : "https://www.pharmgkb.org/data/haplotype/PA166117973",
          "@context" : "https://www.pharmgkb.org/jsonld/haplotype.jsonld",
          "id" : "PA166117973",
          "name" : "S549R(A>C)"
        }, {
          "objCls" : "Haplotype",
          "@id" : "https://www.pharmgkb.org/data/haplotype/PA166117974",
          "@context" : "https://www.pharmgkb.org/jsonld/haplotype.jsonld",
          "id" : "PA166117974",
          "name" : "S549R(T>G)"
        } ],
        "refSeqPosition" : -1,
        "tagGene" : false,
        "type" : "haplotype"
      },
      "strength" : {
        "@id" : "https://www.pharmgkb.org/data/ontologyTerm/guidelineStrength/guidelineStrength:981501931",
        "@context" : "https://www.pharmgkb.org/jsonld/ontologyTerm.jsonld",
        "id" : 981501931,
        "src" : "guidelineStrength",
        "term" : "Moderate",
        "termId" : "guidelineStrength:981501931"
      },
      "textHtml" : "<p>Use ivacaftor according to the product label (e.g., 150 mg every 12 hours for patients age 6 and older without other diseases; modify dose in patients with hepatic impairment).</p>"
    } ]
  } ],
  "relatedDrugs" : [ {
    "objCls" : "Drug",
    "@id" : "https://www.pharmgkb.org/data/drug/PA165950341",
    "@context" : "https://www.pharmgkb.org/jsonld/drug.jsonld",
    "id" : "PA165950341",
    "name" : "ivacaftor"
  } ],
  "relatedGenes" : [ {
    "objCls" : "Gene",
    "@id" : "https://www.pharmgkb.org/data/gene/PA109",
    "@context" : "https://www.pharmgkb.org/jsonld/gene.jsonld",
    "id" : "PA109",
    "symbol" : "CFTR",
    "name" : "cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7)"
  } ],
  "source" : "CPIC",
  "summaryHtml" : "<p>Ivacaftor treatment is recommended only in cystic fibrosis (CF) patients that are either homozygous or heterozygous for certain <em>CFTR</em> variants.  See full guideline for disclaimers, further details and supporting evidence. </p>",
  "textHtml" : "<h3 id=\"April2014UpdateonPharmGKB\">April 2014 Update on PharmGKB</h3><ul><li>After the submission and review of the CPIC guideline manuscript, the <a href=\"/label/PA166104890\">FDA-approved drug label</a> for ivacaftor was updated to include additional variants. In light of these changes, the CPIC guideline annotation on this PharmGKB webpage has been updated to include additional <em>CFTR</em> variants, specifically G1244E (<a href=\"/rsid/rs267606723\">rs267606723</a>), G1349D (<a href=\"/rsid/rs193922525\">rs193922525</a>), G178R (<a href=\"/rsid/rs80282562\">rs80282562</a>), G551S (<a href=\"/rsid/rs121909013\">rs121909013</a>), S1251N (<a href=\"/rsid/rs74503330\">rs74503330</a>), S1255P (<a href=\"/rsid/rs121909041\">rs121909041</a>), S549N (<a href=\"/rsid/rs121908755\">rs121908755</a>) and S549R (<a href=\"/rsid/rs121908757\">rs121908757</a> and <a href=\"/rsid/rs121909005\">rs121909005</a>) (see Table 1 and Figure 1, below).  These variants are not discussed in the 2014 guideline publication.</li></ul><h3 id=\"March2014\">March 2014</h3><p><em>Accepted article preview online March 2014; Advance online publication March 2014.</em></p><ul><li>Guidelines regarding the use of pharmacogenomic tests in determining whether ivacaftor treatment should be undertaken have been published in Clinical Pharmacology and Therapeutics by the Clinical Pharmacogenetics Implementation Consortium (<a href=\"/contributors/consortia/cpic_profile.jsp\">CPIC</a>). </li><li>These guidelines are applicable to <ul><li>cystic fibrosis patients</li><li>pediatrics, 6 years and older</li><li>adults</li></ul></li><li>Download and read:<ul><li><a href=\"/download.do?objCls=Attachment&amp;objId=CPIC_Ivacaftor_PharmGKB_Update.pdf\">Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for Ivacaftor Therapy in the Context of CFTR Genotype</a> </li><li><a href=\"/download.do?objCls=Attachment&amp;objId=CPIC_Ivacaftor_Supplement_PharmGKB_Update.pdf\">2014 supplement</a></li></ul></li></ul><h3 id=\"Table1RecommendedtherapeuticuseofivacaftorbasedonCFTRgenotype\">Table 1: Recommended therapeutic use of ivacaftor based on <em>CFTR</em> genotype</h3><p><em>Adapted from Table 2 of the 2014 guideline manuscript (April 2014 Update on PharmGKB).  Variants have been added to the table below that are not in the published 2014 guideline or supplement; specifically, variants other than G551D and F508del.</em></p><table class=\"table table-striped table-condensed table-hover table-bordered\"><tr><th> CFTR Genotype </th><th> Examples of diplotypes </th><th> Implications for ivacaftor effects  </th><th> Recommendations for ivacaftor therapy </th><th> Classification of recommendation for ivacaftor therapy <sup>c</sup></th></tr><tr><td> Homozygous or Heterozygous G551D-CFTR, <a href=\"/rsid/rs75527207\">rs75527207</a> genotype  AA or AG </td><td> G551D/ F508del, G551D/ G551D </td><td> Significant improvement in lung function, weight, risk of pulmonary exacerbation, patient reported outcomes, and reduction in sweat chloride concentrations through enhanced CFTR channel activity (increase probability of open channel). </td><td> Use ivacaftor according to the product label (e.g., 150 mg every 12 hours for patients age 6 and older without other diseases; modify dose in patients with hepatic impairment) </td><td> Strong </td></tr><tr><td> Homozygous for F508del-CFTR, <a href=\"/rsid/rs113993960\">rs113993960</a> or <a href=\"/rsid/rs199826652\">rs199826652</a> genotype del/del </td><td> F508del/F508del</td><td> No significant reduction in sweat chloride concentrations; no changes in other clinical measurements including spirometric measurements, pulmonary exacerbations, or body weight <sup>b</sup>. Unlikely to respond to treatment. </td><td> Ivacaftor is not recommended <sup>a</sup> </td><td> Moderate <sup>b</sup> </td></tr><tr><td>Homozygous or heterozygous for one of the following <em>CFTR</em> variants that affect gating: G1244E (<a href=\"/rsid/rs267606723\">rs267606723</a> genotype AA or AG), G1349D (<a href=\"/rsid/rs193922525\">rs193922525</a> genotype AA or AG), G178R (<a href=\"/rsid/rs80282562\">rs80282562</a> genotype AA or AG), G551S (<a href=\"/rsid/rs121909013\">rs121909013</a> genotype AA or AG), S1251N (<a href=\"/rsid/rs74503330\">rs74503330</a> genotype AA or AG), S1255P (<a href=\"/rsid/rs121909041\">rs121909041</a> genotype CC or CT), S549N (<a href=\"/rsid/rs121908755\">rs121908755</a> genotype AA or AG), S549R (<a href=\"/rsid/rs121909005\">rs121909005</a> genotype GG or GT, <a href=\"/rsid/rs121908757\">rs121908757</a> genotype CC or CA) <sup>d</sup>  </td><td> F508del/S549N </td><td> Significantly enhanced channel open probability <em>in vitro</em> [Article:<a href=\"/pmid/22293084\">22293084</a>]. <em>In vitro</em> assays with CFBEo- cells expressing S549N-CFTR showed ivacaftor potentiated chloride channel function [Article:<a href=\"/pmid/23027855\">23027855</a>], and a case study showed improved lung function after ivacaftor treatment in a 12-year-old girl with CF with a copy of the S549N variant [Article:<a href=\"/pmid/24081349\">24081349</a>]. </td><td> Use ivacaftor according to the product label (e.g., 150 mg every 12 hours for patients age 6 and older without other diseases; modify dose in patients with hepatic impairment) </td><td> Moderate </td></tr></table><p><sup>a</sup> These recommendations are based on treatment of CF patients with ivacaftor alone and current evidence. Clinical trials are currently underway to investigate ivacaftor alone or in combination with other drugs to treat CF patients with CFTR variants other than G551D, therefore there is potential that ivacaftor may be effective in these patients. See the 2014 guidelines for further details.<br/><sup>b</sup> The recommendation for patients with the F508del/F508del genotype is based on ivacaftor mechanism of action and clinical observational data. The clinical study however was a safety study and was not powered to detect a difference in efficacy [Article:<a href=\"/pmid/22383668\">22383668</a>].<br/><sup>c</sup> Rating scheme described in the 2014 supplement.<br/><sup>d</sup> Variants listed in this table include those added to the amended <a href=\"/label/PA166104890\">drug label for ivacaftor</a> which was approved by the FDA on February 21, 2014. The modifications to this table were made after the acceptance of publication of the 2014 CPIC Ivacaftor-CFTR guideline [Article:<a href=\"/pmid/24598717\">24598717</a>] and are not reflected in the PDFs of the CPIC guideline main manuscript or supplement. </p><h3 id=\"Figure1TreatmentalgorithmforclinicaluseofIvacaftorforcysticfibrosispatientsbasedonCFTRgenotype.\">Figure 1: Treatment algorithm for clinical use of Ivacaftor for cystic fibrosis patients based on <em>CFTR</em> genotype.</h3><p><em>Adapted from Figure 1 of the 2014 guideline manuscript (April 2014 Update on PharmGKB).  Variants have been added to this figure that are not in the published 2014 guideline or supplement; specifically, variants other than G551D and F508del.</em></p><p><img border=\"0\" src=\"/download.do?objCls=Attachment&amp;objId=Slide1.png\"/></p><p><sup>e</sup> Ivacaftor is not recommended for CF patients with other CFTR variants or in patients homozygous for the F508del variant (see 2014 guideline for further details, supporting evidence and disclaimers). Future clinical trials for other CFTR variants are ongoing.    </p>"
}